Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
Duolingo, Inc.
DUOL·Technology
B ★★★Hold
Current$137.75
Target$154.44
Return+12.1%
Aug 8, 2026

Duolingo is the undisputed, highly profitable apex predator of digital education, fortified by a globally addictive gamification moat and an elite Birdbrain algorithm, though its aggressive forward multiple leaves it highly vulnerable to near-term growth deceleration and the looming threat of native AI chatbots.

Score
78
SharkNinja, Inc.
SN·Consumer Discretionary
C ★★Sell
Current$185.52
Aug 8, 2026

SharkNinja operates an elite, agile consumer innovation engine dominating global retail and social commerce, but its absolute valuation premium and lingering accounting control risks render the stock far too expensive to aggressively acquire at current highs.

Score
65
CorVel Corporation
CRVL·Healthcare
A ★★★★Buy
Current$62.45
Target$71.00
Return+13.7%
Aug 8, 2026

CorVel is a highly profitable, debt-free quality compounder transitioning to generative AI-driven claims management, leveraging its massive CERIS payment integrity division to offset the structural industry-wide declines in workers' compensation claim volumes.

Score
85
The Timken Company
TKR·Industrials
B ★★★Hold
Current$131.32
Target$148.80
Return+13.3%
Aug 8, 2026

Timken is masterfully executing a high-margin transformation into an elite industrial motion compounder via aggressive 80/20 portfolio optimization, though the stock's recent 75% surge fully prices in near-term perfection against a fragile global manufacturing macro backdrop.

Score
80
Coca-Cola Europacific Partners PLC
CCEP·Consumer Staples
A ★★★★Buy
Current$108.25
Target$125.00
Return+15.5%
Aug 7, 2026

Coca-Cola Europacific Partners operates an unassailable, cash-printing regional bottling monopoly that utilizes its mature European pricing power to aggressively fund shareholder returns and scale its lucrative Southeast Asian growth engine, though investors must remain vigilant regarding tightening EU packaging regulations.

Score
85
Apollo Global Management, Inc.
APO·Financials
B ★★★Hold
Current$129.74
Target$146.00
Return+12.5%
Aug 7, 2026

Apollo is the undisputed apex predator of private credit origination and permanent capital compounding, trading at a steep discount to asset-light peers, though near-term regulatory shifts (NAIC) and interest rate volatility demand patience before aggressive entry.

Score
83
Itaú Unibanco Holding S.A.
ITUB·Financials
B ★★★Hold
Current$8.49
Target$9.50
Return+11.9%
Aug 7, 2026

Itaú Unibanco continues to deliver unmatched profitability and scale across Latin America with its dominant ROE, though near-term macroeconomic volatility and demanding relative valuation multiples suggest investors await a wider margin of safety.

Score
76
Energy Transfer LP
ET·Energy
A ★★★★Buy
Current$20.59
Target$25.00
Return+21.4%
Aug 7, 2026

Energy Transfer's 140,000-mile network captures AI data center gas demand at a cheap valuation and 6.69% yield, but heavy debt and acquisition-driven dilution require monitoring.

Score
92
Revvity, Inc.
RVTY·Healthcare
A ★★★★Buy
Current$113.69
Target$128.26
Return+12.8%
Aug 7, 2026

Revvity is a highly profitable, cash-generative tollbooth for the AI-driven life sciences revolution, trading at a compelling discount to peers as it sheds legacy assets, though investors must monitor transient lumpiness in enterprise software renewals.

Score
92
Jacobs Solutions Inc.
J·Industrials
B ★★★Hold
Current$144.03
Target$167.90
Return+16.6%
Aug 7, 2026

Jacobs has successfully transformed into a highly profitable, capital-light infrastructure consultancy riding the massive structural tailwinds of AI data centers and global reshoring, though its perfectly fair valuation currently demands patience for a superior entry point.

Score
78
W.W. Grainger, Inc.
GWW·Industrials
B ★★★Hold
Current$1,285.07
Target$1,275.45
Return-0.7%
Aug 7, 2026

W.W. Grainger operates a brutally efficient, highly profitable industrial distribution monopoly shielded by deep enterprise integration, but current valuations offer zero margin of safety ahead of sequential margin compression and unexpected C-suite turnover.

Score
79
Waters Corporation
WAT·Healthcare
B ★★★Hold
Current$399.70
Target$407.40
Return+1.9%
Aug 7, 2026

Waters is an extraordinarily entrenched, highly profitable life sciences tollbooth fortified by the $17.5 billion BD transaction to secure 70% recurring revenue, though investors should await a clearer deleveraging trajectory before aggressively accumulating shares at current multiples.

Score
75